Skip to main content

The Globe and Mail

Stock Analysis: Jean Coutu scores a perfect 10

An exterior shot of Jean Coutu store in Longueuil, Quebec, May 2, 2012.

Christinne Muschi/The Globe and Mail

StockReports+ is a Thomson Reuters service that helps investors pick equities by simplifying the process of evaluating stocks, finding new trading ideas, and understanding trends affecting markets and industries. Globe Unlimited subscribers get unlimited access to these reports from about 7,000 companies, which normally retail for $25 each.

Shares in Jean Coutu Group (PJC) Inc. have been on an impressive ride, rising from below $16 a share to the current trading price of near $22. The pharmacy chain has plans to grow, hoping to expand its presence outside large urban centres amid increased competition and the absence of large acquisition opportunities.

Should investors bet its stock has further upside? This StockReports+ report suggests it could.

Story continues below advertisement

StockReports+ gives each stock an average score that combines the quantitative analysis of six widely-used investment decision-making tools: earnings, fundamentals, relative valuation, risk, price momentum and insider trading. For the past 10 weeks, its score has been 10 out of 10.

Read more in this comprehensive report.

Read other reports here.

Report an error Editorial code of conduct
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.